
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.54 | 0.54 | 0.00 |
Shares | 98.06 | 98.06 | 0.00 |
Other | 1.41 | 1.55 | 0.14 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.73 | 19.62 |
Price to Book | 5.75 | 4.36 |
Price to Sales | 4.92 | 2.36 |
Price to Cash Flow | 16.71 | 15.71 |
Dividend Yield | 1.16 | 1.14 |
5 Years Earnings Growth | 6.34 | 11.11 |
Number of long holdings: 175
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AbbVie | US00287Y1091 | 14.13 | 233.91 | -1.12% | |
Amgen | US0311621009 | 8.82 | 297.89 | +0.16% | |
Gilead | US3755581036 | 8.28 | 112.69 | +1.93% | |
Krystal Biotech | US5011471027 | 7.06 | 183.36 | +0.92% | |
Alnylam | US02043Q1076 | 6.48 | 456.35 | -1.01% | |
argenx ADR | US04016X1019 | 2.73 | 800.00 | +1.06% | |
Insmed | US4576693075 | 2.73 | 157.16 | +2.85% | |
Ascendis Pharma AS | US04351P1012 | 2.50 | 204.05 | +1.53% | |
UCB | BE0003739530 | 2.26 | 252.00 | +2.27% | |
Scholar Rock | US80706P1030 | 1.50 | 37.47 | +6.48% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity 500 Index Institutional Pr | 681.82B | 10.78 | 19.52 | 14.59 | ||
Fidelity Contrafund | 160.4B | 15.64 | 27.85 | 16.71 | ||
Fidelity Total Market Index Instl b | 113.87B | 10.54 | 18.84 | 13.93 | ||
Fidelity Blue Chip Growth | 67.4B | 10.09 | 28.45 | 18.90 | ||
Fidelity Growth Company | 64.44B | 10.78 | 27.12 | 19.87 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review